Charlie Larsen

Charlie E.
Larsen is the founder of NOVT Corp., founded in 1987, Novoste Corp., founded in 1987, Namic Caribe, Inc., founded in 1987, LipoSonix, Inc., founded in 1999, Cerebral Vascular Applications, Inc., founded in 1999, The Innovation Factory LLC, founded in 1999, Neuronetics, Inc., founded in 2001, NeoVista, Inc., founded in 2002, Accuitive Medical Ventures LLC, founded in 2004, Halscion, Inc., founded in 2005, AqueSys, Inc., founded in 2006, and Sebacia, Inc., founded in 2010.
Titles held at these companies included Chief Executive Officer at Cerebral Vascular Applications, Inc. in 2012, Director at Novoste Corp.
from 1987 to 2003, Director & Vice President at Namic Caribe, Inc. in 1992, Chairman & Chief Technical Officer at AqueSys, Inc., Vice Chairman at The Innovation Factory LLC since 2011, and Managing Director at Accuitive Medical Ventures LLC since 2011.
Mr. Larsen was also the founder of AcuFocus, Inc...
Mr. Larsen was previously Chairman at Femasys, Inc. since 2022 and Director at CardioFocus, Inc. Mr. Larsen was Chairman & Secretary at NovaLign Orthopaedics, Inc. from 2009 to 2013, Independent Director at Inogen, Inc. from 2006 to 2014, Director at Torax Medical, Inc., Director at Intuity Medical, Inc., Manager-Manufacturing Engineering at Cordis Corp.
from 1983 to 1987, Chief Technology Officer at Cellutions, Inc., and Principal at Parke, Davis & Co. LLC.
Education includes undergraduate studies at New Jersey Institute of Technology.